![](https://monteverdelaw.com/wp-content/uploads/case-logo/rocket-pharmaceuticals-inc.jpg)
Rocket Pharmaceuticals, Inc. (Nasdaq: RCKT), relating to its proposed acquisition of Renovacor, Inc. Under the terms of the agreement, Renovacor shareholders will receive 0.1676 shares of RCKT per share they own.
Rocket Pharmaceuticals, Inc. (Nasdaq: RCKT), relating to its proposed acquisition of Renovacor, Inc. Under the terms of the agreement, Renovacor shareholders will receive 0.1676 shares of RCKT per share they own.